The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

CStone and Kimia partner on Phase I development of DDR oncology asset

Nov 4, 2026 00:10 (4h ago)

Verifying

CStone and Kimia agreed to jointly advance a potential first-in-class oncology asset.
CStone will lead Phase I development in mainland China and Australia.
Kimia’s lead oncology program is scheduled to enter clinical development in Q1 2027.